Top Markets
Coin of the day
Actuate Therapeutics Inc Actuate Therapeutics Inc

Actuate Therapeutics Inc

ACTU
Kedudukan dalam Saham #28698
Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the... Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma. Furthermore, Elraglusib is being developed to address other malignancies, including Ewing sarcoma, metastatic melanoma, and colorectal cancer. Originally named Apotheca Therapeutics, Inc., the organization rebranded as Actuate Therapeutics, Inc. in October 2015. Established in 2015, the company maintains its headquarters in Fort Worth, Texas.
Harga Saham
$1.05
Disegerakkan terakhir: 2026-08-19
Modal Pasaran
$25.12M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-86.33%
Negara
US
Perdagangan Actuate Therapeutics Inc (ACTU)

Kategori

Sejarah pecahan saham untuk Actuate Therapeutics Inc (ACTU)
Saham Actuate Therapeutics Inc (simbol: ACTU) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 20, 2026.
Satu saham ACTU yang dibeli sebelum Aug 20, 2026 kini bersamaan dengan 0 saham ACTU.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH